-
Product Insights
Duchenne Muscular Dystrophy Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2025" provides an overview of Duchenne Muscular Dystrophy Clinical trials scenario. This report provides top line data relating to the clinical trials on Duchenne Muscular Dystrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Global Clinical Trials Review, 2025" provides an overview of Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Clinical trials scenario. This report provides top line data relating to the clinical trials on Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers...
-
Product Insights
Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) - Global Clinical Trials Review, 2025" provides an overview of Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) Clinical trials scenario. This report provides top line data relating to the clinical trials on Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Product Insights
Graft Versus Host Disease (GVHD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Graft Versus Host Disease (GVHD) - Global Clinical Trials Review, 2025" provides an overview of Graft Versus Host Disease (GVHD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Graft Versus Host Disease (GVHD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Seasonal Influenza Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Seasonal Influenza - Global Clinical Trials Review, 2025" provides an overview of Seasonal Influenza Clinical trials scenario. This report provides top line data relating to the clinical trials on Seasonal Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Aplastic Anemia Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Aplastic Anemia - Global Clinical Trials Review, 2025" provides an overview of Aplastic Anemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Aplastic Anemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Neuropathic Pain (Neuralgia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Neuropathic Pain (Neuralgia) - Global Clinical Trials Review, 2025" provides an overview of Neuropathic Pain (Neuralgia) Clinical trials scenario. This report provides top line data relating to the clinical trials on Neuropathic Pain (Neuralgia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Chemotherapy-Induced Diarrhea (CID) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2025 Update
GlobalData's clinical trial report, “Chemotherapy-Induced Diarrhea (CID) - Global Clinical Trials Review, 2025" provides an overview of Chemotherapy-Induced Diarrhea (CID) Clinical trials scenario. This report provides top line data relating to the clinical trials on Chemotherapy-Induced Diarrhea (CID). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
Cell and Gene Therapies in Dermatology Disorders - Therapeutic Analysis, Treatment Options, Pricing and Reimbursement and Future Market
Currently, there are seven marketed cell and gene therapies (CGTs) for various dermatology disorders. This includes one gene therapy and six cell therapies. Biosolution’s KeraHeal, indicated for the treatment of burns in pediatric and adult patients, was the first autologous keratinocyte cell-based therapy to receive approval in the dermatology market in 2006, by the Ministry of Food and Drug Safety (MFDS) in South Korea. Over the past decade, there has been an increase in the number of approved CGTs for...
-
Thematic Analysis
Geopolitical, Macroeconomic, and Regulatory Changes Impacting the Pharmaceutical Industry
Within the first 100 days of the current US Administration, there have been a series of changes in the US that will impact the pharmaceutical industry. To date, key outcomes have included: • Leadership changes across the Department of Health and Human Services (HHS) • Major cuts across key departments and health programs • Additional regulations that may curb investments • Introduction of a reciprocal tariff framework • Significant tariffs on strategic sectors such as steel, aluminum, and automotive and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.